Vasundhara Rasayans Limited (BOM:538634)
146.95
+1.75 (1.21%)
At close: Sep 11, 2026
Vasundhara Rasayans Revenue
Vasundhara Rasayans had revenue of 69.32M INR in the quarter ending June 30, 2026, a decrease of -8.32%. This brings the company's revenue in the last twelve months to 350.94M, up 3.46% year-over-year. In the fiscal year ending March 31, 2026, Vasundhara Rasayans had annual revenue of 357.23M with 5.10% growth.
Revenue (ttm)
350.94M
Revenue Growth
+3.46%
P/S Ratio
1.33
Revenue / Employee
8.36M
Employees
42
Market Cap
467.04M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 357.23M | 17.33M | 5.10% |
| Mar 31, 2025 | 339.90M | -30.28M | -8.18% |
| Mar 31, 2024 | 370.18M | -9.23M | -2.43% |
| Mar 31, 2023 | 379.41M | 111.91M | 41.83% |
| Mar 31, 2022 | 267.50M | 40.71M | 17.95% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Smruthi Organics | 1.12B |
| Kimia Biosciences | 1.12B |
| Panchsheel Organics | 1.08B |
| Tyche Industries | 500.33M |
| Auro Laboratories | 367.34M |
| Crestchem | 338.33M |
| Krebs Biochemicals & Industries | 252.34M |
| Ishita Drugs and Industries | 124.05M |